News | Remote Monitoring | May 08, 2023

Ucardia Announces Acquisition of PHAS3; Launches Cardiologist Practice Remote Patient Monitoring Offering

Ucardia, a cardiac conditioning software developer, announced that it has reached an agreement to acquire Phas3 

Ucardia, a cardiac conditioning software developer, announced today that it has reached an agreement to acquire Phas3

Ucardia Co-founders, Curtis Petersen and Nick Weber 


May 8, 2023 — Ucardia, a cardiac conditioning software developer, announced today that it has reached an agreement to acquire Phas3, a pioneer in home-based cardiac rehab and fellow industry leader. This acquisition will result in a comprehensive, market-leading solution for providers, payers, and consumers, covering all facets of cardiac rehabilitation, conditioning, and remote monitoring for patients affected by cardiovascular disease (CVD). 

"With Phas3's compelling software that allows clinicians a convenient way to remotely monitor and engage their cardiac patients, we are confident we have a market-first product that truly allows for patient- and provider-partnered cardiac care for all modalities of remote care – from patients immediately post-discharge from a cardiac event who cannot attend traditional cardiac rehab, to patients looking for a supervised program to strengthen their heart at home," said Nick Weber, Ucardia's co-founder and CEO. 

Ucardia and Phas3 will continue to support all existing customers and their patients in the companies' joint portfolio and are excited to begin planning exciting new products and services that take advantage of their combined strengths. 

"We are pleased to join the Ucardia family and share the company's vision of serving even more CVD patients with our unique and powerful combination of software and clinical services" said Lucas Rydberg, Phas3's co-founder and CEO. 

Jointly with this acquisition, Ucardia is announcing its newest offering, Ucardia-at-Home, a comprehensive remote patient monitoring platform that enables cardiologists and physician practices to enhance the monitoring, engagement, education, and self-management of patients between traditional doctor visits and close the gap in patient care management. 

"We see serving the physician practice segment as a natural extension of the missions of both Phas3 and Ucardia – continuing to make sure every CVD patient has the opportunity to receive critical monitoring and care while in the comfort and convenience of their home," said Dan Ebeling, co-founder and COO of Phas3. "We believe in extending access to every patient who needs this essential care." 

For more information: www.ucardia.com


Related Content

Feature | Cardiovascular Business

May 24, 2023 — Park Ridge, N.J.-based publisher Wainscot Media has named Laura Dowden as managing director, group ...

Home May 24, 2023
Home
News | Cardiovascular Business

May 3, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) Board of Directors is proud to announce that ...

Home May 03, 2023
Home
News | Cardiovascular Business

May 2, 2023 — Auburn Community Hospital (ACH) announced today that Dr. Ronald L. Kirshner has been appointed Chair and ...

Home May 02, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

As we head into Spring, let's take a look at the Top 10 topics that viewers were reading about during the month of April ...

Home May 01, 2023
Home
Feature | Cardiovascular Business | By Emily Gilbert and Kamran Zamanian, PhD

The European interventional cardiology device market is one of the larger markets in the global space. The market is ...

Home April 24, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

In the blink of an eye yet another month has passed, and here is a look at the Top 10 of what DIcardiology.com viewers ...

Home April 03, 2023
Home
News | Cardiovascular Business

March 29, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

Home March 29, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

Home March 01, 2023
Home
News | Cardiovascular Business

February 17, 2023 — Internationally recognized cardiologist in heart transplantation Jon Kobashigawa, MD, director of ...

Home February 17, 2023
Home
News | Cardiovascular Business

February 9, 2023 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has entered into a long ...

Home February 09, 2023
Home
Subscribe Now